Mass Balance and Drug Interaction Potential of Intravenous Eravacycline Administered to Healthy Subjects

Eravacycline is a novel, fully synthetic fluorocycline that is approved for the treatment of complicated intra-abdominal infections (cIAI) in adult patients. We report results from three studies in healthy subjects that investigated the distribution, metabolism, and excretion of intravenous (i.v.) e...

Descripción completa

Detalles Bibliográficos
Autores principales: Newman, Joseph V., Zhou, Jian, Izmailyan, Sergey, Tsai, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395926/
https://www.ncbi.nlm.nih.gov/pubmed/30559132
http://dx.doi.org/10.1128/AAC.01810-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395926/
https://www.ncbi.nlm.nih.gov/pubmed/30559132
http://dx.doi.org/10.1128/AAC.01810-18

Ejemplares similares